chain function minim disrupt
messag base respons proprietari consum survey
commentari number health care compani believ suppli chain
oper rel minim disrupt continu believ group well
posit current investor expect addit mani
retail closed/und pressur current environ believ drug retail
increment benefit consider essenti retail appreci
script growth may modestli impact temporari postpon doctor
visit procedur believ pullback group overshadow
defens posit busi model rate buy neutral rate
pt
bottom line conduct survey consum get better understand
purchas pattern overal behavior current environ domin
high-level take-away result read gener posit
pharmaceut suppli chain relat prescript fulfil drug retail
purchas suggest rel minim disrupt see survey
takeaway high level survey suggest current environ script
get fill degre regular consum shop drug
retail busi benefit handicap competit balanc
clear mani consum postpon physician appoint elect procedur
believ may weigh modestli script growth given defens natur retail
pharmaci rel stabil suggest survey result surpris
recent rel under-perform ytd
respect vs expect compani net beneficiari
current environ note ytd uniqu
situat bolster bullish march virtual analyst day paint
pictur greater expect stabil recommend investor take advantag
weak would expect buoy nt
stabil busi current volatil environ
survey take-away script seemingli get fill minim disrupt
adjust lower physician visit survey ask consum fill
script normal would despit environ result suggest
consum exist prescript fill medic normal
basi view suggest rel stabil pharmaci sale highlight
appreci script may delayed/lost physician visit elect procedur
postpon may weigh overal script growth believ
varieti offset make drug retail net beneficiari current environ
notabl better expect front-end sale busi benefit
essenti retail statu less competit usual
page analyst certif import disclosur
survey take-away expect physician hospit visit postpon
like weigh near-term script growth survey indic
household cancel primari care appoint due
schedul impact may weigh script growth near term creat somewhat
headwind distributor retail pharmaci appreci caveat
analysi exampl miss physician visit may alway directli correl
miss prescript depend condit altern channel furthermor
would expect investor larg look past issu believ visit
ultim reschedul physician activ resort normalci point
time howev broadli speak believ dynam worth keep mind
separ physician visit household also indic cancel
medic procedur due could potenti carri benefit health
benefit portion busi near-term busi mix shift toward
treatment lower expens rel mani expens elect procedur
survey take-away drug retail design essenti retail may give
front store unexpect bump mani retail requir close
outbreak drug retail deem essenti continu oper
rel normal basi view would reason consum shift
amount non-essenti shop on-line howev survey indic rel
pre-covid habit consum either shop amount
drug retail believ busi abl remain open posit benefit
consum stock critic item like food toilet paper sanit suppli
result front store traffic drug retail like remain elev long
condit persist said would note long-term consum spend could
impact would highlight averag consum survey indic belief
economi like enter recess overal level spend could
potenti flat crisi
page analyst certif import disclosur
 posit multipl front
pois weather storm mandat social distanc
larg brought econom activ standstil howev deem
essenti allow remain open busi believ fewer option
avail like experienc influx custom look stock essenti
suppli medic shelter home view increment traffic
benefici front-end retail pharmaci busi similarli survey
indic consum continu fill prescript regular basi
indic disrupt area economi necessarili impact
pharmaci level addit consum activ work maintain distanc
expect pbm mail-ord pharmaci busi net beneficiari anoth area
busi believ could experi tailwind period disrupt
compani health benefit segment hospit oper near full
capac care surg patient elect procedur
part put hold elect procedur tend much costlier treat
compar flu-lik symptom covid like near-term benefit
cost side busi said acknowledg elect procedur
like still happen outbreak pass could becom headwind futur
guidanc could tweak difficult quantifi move
relat factor may push pull earn gener believ
compani remain track primari object despit volatil environ
said expect compani fine tune estim acknowledg
realiti situat coupl thing believ could impact model includ
script growth revenu come slightli expect shelter-in-plac
order like impact revenu growth
believ compani could consid ad addit liquid sure financi
posit current environ
expect compani slow roll-out hub transform
potenti reassess target synergi attach enterpris modern program
given move piec believ manag could tweak origin guidanc
ep growth vs baselin would expect move materi
way remind investor varieti tailwind benefit
result particular increment run-rat synergi aet transact
cost save enterpris modern program potenti better
gener introduct environ vs lap increment
oper invest least expect allevi
encourag recent rais guidanc fiscal year note
page analyst certif import disclosur
largest custom fair manag attribut rais
company-specif event declin comment current market condit view
manag decis rais guidanc current econom disrupt indic
core drug distribut busi like healthi view posit
yield valuat remain compel share pull back ytd
vs estim compani gener roughli
yield view compani healthi cash gener help set valuat
floor stock estim annual next sever year
believ manag enough oper flexibl navig current
econom volatil mitig long-term impact continu pay debt
invest busi moreov recent pullback share compani
trade ebitda estim rel histor averag
continu appreci lt concern continu believ retail pharmaci
model structur challeng one main issu reimburs pressur
like continu could weigh compani gross margin addit competit
on-line retail drive foot traffic away store pressur
pharmaci front store busi near term believ tailwind
discuss like off-set long-term pressur appreci long-
expect head earn week lt
reason nt setup print expect share nt benefit
higher foot traffic front-stor sale relat would like top
manag previous highlight strong decemb month mid-singl
digit script growth long-term question remain discuss acknowledg
nt tailwind combin rel low expect contribut
attract nt risk/reward result
lt strategi competit concern continu limit upsid twelve-
month perspect continu believ upsid share may limit
still uncertain lt strategi busi high level continu face
structur headwind reimburs pressur dynam well
understood invest commun manag yet demonstr clear path
sustain off-set pressur time recent competit environ
come focu follow rel soft result driven lower expect
prescript volum growth saw market share declin y/i quarter
manag also highlight see lower perform aetna relationship
lead investor believ continu gain ground achiev
guidanc need achiev script growth remaind
year signific step report separ us
oper also carri uniqu exposur intern market retail
wholesal oper share struggl carri greater
uncertainti environ mind along recent
execut challeng investor acut focu understand lt vision believ
need sever quarter execut gener sustain upsid share
appreci yield valuat discount varieti concern
around appreci import acknowledg context
valuat carri yield estim trade discount
peer averag discount histor averag ev/ebitda
basi believ mani investor concern around reflect valuat
admittedli increment intrigu situat follow anoth signific
pullback stock would also remiss acknowledg mani media report
fall suggest engag potenti discuss around lbo
increment insight legitimaci discuss appreci
share sinc initi wsj report vs
 potenti convers resurfac invest commun
said believ challeng experi meaning
page analyst certif import disclosur
sustain multipl expans fundament basi given investor acut focu
lt vision remain neutral rate
better posit still oper
recent analyst day paint pictur stabil host analyst day
well receiv investor believ gener de-risk
result expect compani rais guidanc offer gener in-
line outlook offer encourag target includ adjust ebitda
growth growth improv leverag ratio compani begin
demonstr benefit optim store footprint streamlin oper
combin step taken restructur debt tender
note push heavili scrutin debt matur compani
still note matur expect manag continu
aggress pay debt opportunist restructur overal recogn
on-going structur challeng would suggest gener stabl
oper posit compar time last year
structur challeng continu limit upsid despit demonstr stabil
difficult ignor on-going structur challeng retail pharmaci still high
leverag balanc sheet still face continu reimburs pressur
given competit environ retail pharmaci combin increment e-
commerc competit front end busi balanc sheet perspect
still carri net leverag describ expect compani
continu make stride toward navig debt payment believ investor concern
around liquid persist weigh sentiment furthermor note signific
catalyst rear-view manag alreadi offer guidanc
long-term target go forward believ need develop track record
posit execut order experi meaning sustain multipl expans
compani may better path varieti lt risk around oper
page analyst certif import disclosur
valuat risk
revis price target base ev/ebitda vs prior valuat
target valuat repres premium suppli chain peer current trade believ warrant given
diversifi natur busi growth driver synergi cost save lower multipl vs prior valuat
reflect econom impact given potenti upsid price target maintain buy rate risk
downsid potenti execut issu given magnitud integr aetna anoth risk downsid
potenti acceler reimburs pressur retail pharmaci busi
valu ev/ebitda basi given leverag compani balanc sheet maintain neutral rate
view biggest risk downsid compani unabl refin remain debt biggest risk upsid
acceler front-end sale driven compani statu essenti busi outbreak
valu ev/ebitda basi given leverag compani balanc sheet maintain neutral rate
main risk upsid acceler allevi reimburs pressur favor gener price main risk
downsid intensifi competit environ drive lower reimburs rate potenti on-line player take market
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst whose name appear report receiv compens base upon variou factor includ qualiti research
investor client feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc manag co-manag public offer secur health corpor past month
health corpor period preced date distribut report client guggenheim secur llc
guggenheim secur llc affili receiv compens invest bank servic health corpor past
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
corpor rite aid corpor next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori health corpor
rate price target histori walgreen boot allianc
creat bluematrix
page analyst certif import disclosur
